Fuxiang Co., Ltd. is a developer of raw materials and intermediates, mainly engaged in the R&D and production of β -lactamase inhibitor raw materials and carbapenems, and provides related technical support services to users. These products include tazobactam, sultamicillin and meropenem.
More peer analysis, the company knows and understands.